172 related articles for article (PubMed ID: 2484311)
1. The relevance of animal tumour models to the preclinical screening of cytokines.
Kelly SA; Malik ST; Balkwill FR
Cancer Surv; 1989; 8(4):741-54. PubMed ID: 2484311
[TBL] [Abstract][Full Text] [Related]
2. Experimental design for the evaluation of the antitumor action of cytokines.
Ciolli V; Sestili P; Brigato M; Gabriele L; Varano F; Locardi C; Belardelli F
Ann Ist Super Sanita; 1990; 26(3-4):441-51. PubMed ID: 2091505
[TBL] [Abstract][Full Text] [Related]
3. Cytokines (IFNs, TNF-alpha, IL-2 and IL-12) and animal models of cancer.
Burke F
Cytokines Cell Mol Ther; 1999 Mar; 5(1):51-61. PubMed ID: 10390079
[TBL] [Abstract][Full Text] [Related]
4. [Cytokines in clinical medicine].
Nordstedt C; Kvanta A; Holm G
Lakartidningen; 1989 Mar; 86(10):834, 836, 838. PubMed ID: 2466182
[No Abstract] [Full Text] [Related]
5. Biological Response Modifiers Programme and cancer chemotherapy.
Oldham RK
Int J Tissue React; 1982; 4(3):173-88. PubMed ID: 6183193
[TBL] [Abstract][Full Text] [Related]
6. Orthotopic metastatic (MetaMouse) models for discovery and development of novel chemotherapy.
Hoffman RM
Methods Mol Med; 2005; 111():297-322. PubMed ID: 15911987
[TBL] [Abstract][Full Text] [Related]
7. The therapeutic activity in cancer of IL-2 in combination with other cytokines.
Truitt GA; Brunda MJ; Levitt D; Anderson TD; Sherman MI
Cancer Surv; 1989; 8(4):875-89. PubMed ID: 2701733
[TBL] [Abstract][Full Text] [Related]
8. Establishment of human tumor xenografts in immunodeficient mice.
Morton CL; Houghton PJ
Nat Protoc; 2007; 2(2):247-50. PubMed ID: 17406581
[TBL] [Abstract][Full Text] [Related]
9. Lymphokines and cytokines.
Wagstaff J; Melief KJ
Cancer Chemother Biol Response Modif; 1987; 9():432-53. PubMed ID: 2484327
[TBL] [Abstract][Full Text] [Related]
10. Lymphokines and cytokines.
Wagstaff J; Melief K
Cancer Chemother Biol Response Modif; 1988; 10():416-33. PubMed ID: 2484321
[No Abstract] [Full Text] [Related]
11. Effects of interferons and other cytokines on tumors in animals: a review.
Thomas H; Balkwill FR
Pharmacol Ther; 1991 Dec; 52(3):307-30. PubMed ID: 1726476
[TBL] [Abstract][Full Text] [Related]
12. Human tumour xenografts.
Double JA
Biomedicine; 1975 Nov; 22(6):461-5. PubMed ID: 773441
[TBL] [Abstract][Full Text] [Related]
13. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
[TBL] [Abstract][Full Text] [Related]
14. On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing.
Man S; Munoz R; Kerbel RS
Cancer Metastasis Rev; 2007 Dec; 26(3-4):737-47. PubMed ID: 17846863
[TBL] [Abstract][Full Text] [Related]
15. Human colorectal tumor xenografts in nude mice: expression of malignancy.
Sordat B; Wang WR
Behring Inst Mitt; 1984 May; (74):291-300. PubMed ID: 6477358
[TBL] [Abstract][Full Text] [Related]
16. Preclinical approaches to the treatment of metastatic disease: therapeutic properties of rH TNF, rM IFN-gamma, and rH IL-2.
Talmadge JE; Black PL; Tribble H; Pennington R; Bowersox O; Schneider M; Phillips H
Drugs Exp Clin Res; 1987; 13(6):327-37. PubMed ID: 3115744
[TBL] [Abstract][Full Text] [Related]
17. Role of murine tumor models in cancer treatment research.
Martin DS; Balis ME; Fisher B; Frei E; Freireich EJ; Heppner GH; Holland JF; Houghton JA; Houghton PJ; Johnson RK
Cancer Res; 1986 Apr; 46(4 Pt 2):2189-92. PubMed ID: 3948188
[TBL] [Abstract][Full Text] [Related]
18. Biologic and immunomodulating factors in the treatment of pediatric acquired immunodeficiency syndrome.
Ammann AJ
Pediatr Infect Dis J; 1990 Dec; 9(12):894-904. PubMed ID: 1703652
[No Abstract] [Full Text] [Related]
19. The growth and therapeutic response of human tumours in immune deficient mice.
Steel GG
Bull Cancer; 1978; 65(4):465-72. PubMed ID: 371709
[TBL] [Abstract][Full Text] [Related]
20. Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development.
Kelland LR
Eur J Cancer; 2004 Apr; 40(6):827-36. PubMed ID: 15120038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
